Insulin-like growth factor-II in the cycle of life

Biomedical Reviews

Volumn 5, Issue , 1996, Pages 65-71

  Van Buul Offers, Sylvia C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

GROWTH REGULATION; HUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; REVIEW;

EID: 0029845190     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v5.184     Document Type: Review

References (61)

1. Daughaday WH, Rotwein P. Insulin-like growth actors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68-91
2. Baxter RC. Insulin-like growth actor binding proteins in the human circulation: A review. Horm Res 1994; 42: 140-144
3. Zapf J. Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 1995; 132: 645-654
4. Glasscock GF, Gelber SE, Lamson G, McGee-Tekula R, Rosenfeld RG. Pituitary control of growth in the neonatal rat: Effects of neonatal hypophysectomy on somatic and organ growth, serum insulin-like growth actors (IGF)-I and -II levels, and expression of IGF binding proteins. Endocrinology 1990; 127: 1792-1803
5. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16: 3-34
6. Duguay SJ, Chan SI, Mommsen TP, Steiner DF. Divergence of insulin-like growth actors I and II in the elasmobranch, Squalus acanthias. FEBS Lett 1995; 371: 69-72
7. LeRoith D, Kavsan VM, Koval AP, Roberts Jr CT. Phylogeny of the insulin-like growth factors (IGFs) and receptors: A molecular approach. Mol Reprod Dev 1993; 35: 332-338
8. Jansen M, de Moor CH, Sussenbach JS, Van den Brande JL. Translational control of gene expression. Pediat Res 1995; 37: 681-686
9. Holthuizen PE, Cleutjens CBJM, Veenstra GJC, Van der Lee FM, Koonen-Reemst AMCB, Sussenbach JS. Differential expression of the human, mouse and rat IGF-II genes. Regul Pept 1993; 48: 77-89
10. Doherty AS, Temeles GL, Schultz RM. Temporal pattern of IGF-I expression during mouse preimplantation embryogenesis. Mol Reprod Dev 1994; 37: 21-26
11. Heyner S, Garside WT. Biological actions of IGFs in mammalian development. BioEssays 1994; 16: 55-57
12. Logan A, Gonzalez AM, Hill DJ, Berry M, Gregson NA, Baird A. Coordinated pattern of expression and localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 in the adult rat brain. Endocrinology 1994; 135: 2255-2264
13. Sullivan KA, Feldman EL. Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. Endocrinology 1994; 135: 540-547
14. Shinar DM, Endo N, Halperin D, Rodan GA, Weinreb M. Differential expression of insulin-like growth factor-1 (IGF-I) and IGF-II messenger ribonucleic acid in growing rat bone. Endocrinology 1993; 132: 1158-1167
15. Körner C, Nuernberg B, Uhde M, Braulke T. Mannose 6-phosphate/insulin-like growth factor II receptor fails to interact with G-proteins. Analysis of mutant cytoplasmic receptor domains. J Biol Chem 1995; 270 :287-295
16. Martinez DA, Zuscik MJ, Ishibe M, Rosier RN, Romano PR, Cushing JE et al. Identification of functional insulin-like growth factor-II mannose-6-phosphate receptors in isolated bone cells. J Cell Biochem 1995; 59: 246-257
17. Kiess W, Yang Y, Kessler U, Hoeflich A. Insulin-like growth factor II (IGF-II) and the IGF-II/mannose-6-phospate receptor: The myth continues. Horm Res 1994; 41: 66-73
18. Giudice LC, Saleh W. Growth factors in reproduction. Trends Endocrinol Metab 1995; 6: 60-69
19. Liu L, Greenberg S, Russell SM, Nicoll CS. Effects of insulin-like growth factors I and II on growth and differentiation of transplanted rat embryos and fetal tissues. Endocrinology 1989; 124: 3077-3082
20. Rappolee DA, Sturm KS, Behrendtsen O, Schultz GA, Pedersen RA, Werb Z. Insulin-like growth factor II acts through an endogenous growth pathway regulated by imprinting in early mouse embryos. Genes Dev 1992; 6: 939-952
21. Schoenle E, Zapf J, Hauri C, Steiner T, Froesch ER. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol 1985; 108: 167-174
22. Conlon MA, Francis GL, Tomas FM, Wallace JC, Howarth GS, Ballard FJ. Continuous 14 day infusion of IGF-II increases the growth of normal female rats, but exhibits a lower potency than IGF-I. J Endocrinol 1995; 144: 91-98
23. Van Buul-Offers SC, Reijnen-Gresnigt MG, Hoogerbrugge CM, Bloemen RJ, Kuper CF, Van den Brande JL. Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology 1994; 135: 977-985
24. Guler H-P, Zapf J, Schmid C, Froesch ER. Insulin-like growth factors I and II in healthy man. Acta Endocrinol 1989; 121: 753-758
25. Conlon MA, Tomas FM, Owens PC, Wallace JC, Howarth GS, Ballard FJ. Long R3 insulin-like growth factor-I (IGF-I) infusion stimulates organ growth but reduces plasma IGF-I, IGF-II and IGF binding protein concentrations in the guinea pig. J Endocrinol 1995; 146: 247-253
26. Spencer GSG, Decuypere E, Buyse J, Hodgkinson SC, Bass JJ, Zeman M. Passive immunization of insulin-like growth factor (IGF)-1 and of IGF-1 and IGF-2 in chickens. Comp Biochem Physiol 1995; 110C: 29-33
27. Koea JB, Breier BH, Shaw JHF, Gluckman PD. A possible role for IGF-II: Evidence in sheep for in vivo regulation of IGF-I mediated protein anabolism. Endocrinology 1992; 130: 2423-2425
28. Upsala AL, Powell JG, DiMarchi R, Holcombe J, Pories W, Harris GD. Effect of insulin-like growth factor two (IGF-II) on insulin resistance (IR) and severe hyperlipidemia in a patient with berardinelli lipodystrophy and severe IR [abstract]. The 77th Annual Meeting of the Endocrine Society 1995; P3-283: 539A
29. Xu RJ, Mellor DJ, Birtles MJ, Breier BH, Gluckman PD. Effects of oral IGF-I or IGF-II on digestive organ growth in newborn piglets. Biol Neonate 1994; 66: 280-287
30. Donovan SM, Odle J. Growth factors in milk as mediators of infant development. Annu Rev Nutr 1994; 14: 147-167
31. Prosser CG, Davis SR, Farr VC, Moore LG, Gluckman PD. Effects of close-arterial (external pudic) infusion of insulin-like growth factor-II on milk yield and mammary blood flow in lactating goats. J Endocrinol 1994; 142: 93-99
32. Geenen V, Achour I, Robert F, Vandersmissen E, Sodoyez JC, Defresne MP et al. Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus 1993; 21: 115-127
33. Van Buul-Offers SC, De Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL et al. Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus. J Endocrinol 1995; 144: 491-502
34. Kooijman R, Van Buul-Offers SC, Scholtens LE, Schuurman HJ, Van den Brande LJ, Zegers BJM. T cell development in insulin-like growth factor-II transgenic mice. J Immunol 1995; 154: 5736-5745
35. Beilharz EJ, Bassett NS, Sirimanne ES, Williams CE, Gluckman PD. Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Mol Brain Res 1995; 29: 81-91
36. Near SL, Whalen LR, Miller JA, Ishii DN. Insulin-like growth factor II stimulates motor nerve regeneration. Proc Natl Acad Sci USA 1992; 89: 11716-11720
37. Lauterio TJ, Marson L, Daughaday WH, Baile CA. Evidence for the role of insulin-like growth factor II (IGF-II) in the control of food intake. Physiol Behav 1987; 40: 755-758
38. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994; 269: 13779-13784
39. Ward A, Bates P, Fisher R, Richardson L, Graham CF. Disproportionate growth in mice with Igf-2 transgenes. Proc Natl Acad Sci USA 1994; 91: 10365-10369
40. Wolf E, Kramer R, Blum WF, Foell J, Brem G. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: Endocrine changes and effects on body and organ growth. Endocrinology 1994; 135: 1877-1886
41. Baker J, Liu J-P, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73-82
42. Lau MMH, Stewart CEH, Liu Z, Bhatt H, Rotwein P, Stewart CL. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes Dev 1994; 8:2953-2963
43. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor-I (IGF-I) and type I IGF receptor (IGFIr). Cell 1993; 75: 59-72
44. Araki E, Lipes MA, Patti ME, Bruening JC, Haag B, Johnson RS et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372: 186-190
45. Xu Y, Goodyer CG, Deal C, Polychronakos C. Functional polymorphism in the parental imprinting of the human IGF2Rgene. Biochem Biophys Res Commun 1993; 197: 747-754
46. Haig D, Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell 1991; 64: 1045-1046
47. LeRoith D, Baserga R, Helman L, Roberts Jr CT. Insulin-like growth factors and cancer. Ann Intern Med 1995; 122: 54-59
48. Sullivan KA, Castle VP, Hanash SM, Feldman EL. Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 1995; 147: 1790-1798
49. Daughaday WH, Trivedi B, Baxter RC. Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF-binding protein-3 and acid labile subunit and leads to elevation of serum free IGF-II. Endocrine 1995; 3: 425-428
50. Hedborg F, Holmgren L, Sandstedt B, Ohlsson R. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome. Am J Pathol 1994; 145: 802-817
51. Vu TH, Yballe C, Boonyanit S, Hoffman AR. Insulin-like growth factor II in uterine smooth muscle tumors: Maintenance of genomic imprinting in leiomyoma and loss of imprinting in leiomyosarcoma. J Clin Endocrinol Metab 1995; 80: 1670-1676
52. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF. Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 1995; 72: 1189-1193
53. Westley BR, May FEB. Insulin-like growth factors: The unrecognised oncogenes. Br J Cancer 1995; 72: 1065-1066
54. Long L, Rubin R, Baserga R, Brodt P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res 1995; 55: 1006-1009
55. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R et al. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 1994; 54: 2218-2222
56. Surmacz E, Sell C, Swantek J, Kato H, Roberts Jr CT, LeRoith D et al. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor. Exp Cell Res 1995; 218: 370-380
57. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462
58. Naik P, Christofori G, Hanahan D. Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis. Cold Spring Harbor Symp Quant Biol 1994; 59: 459-470
59. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R. Correlation between apoptosis, tumorige-nesis, and levels of insulin-like growth factor I receptors. Cancer Res 1995; 55: 3739-3741
60. Hanks H Wurst W, Anson-Cartwright L, Auerbach AB, Joyner AL. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 1995; 269: 679-682
61. Jung CG. Mandata symbolism. Princeton University Press, Princeton, 1973